Morgan Ventures (526237)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at ₹48.06 against book value of ₹84.00, a 43% discount (P/B 0.57), offering a margin of safety if assets are genuine.
• ROCE of 18.33% indicates the underlying capital has historically generated attractive returns.
• Debt/Equity reported as N/A, suggesting leverage may be negligible for this NBFC.
• Small market cap of ₹50 Cr leaves limited downside if liquidation value is realized.

Concerns

• Sales growth is -91.08% and profit growth is -159.48%; the latest quarter shows a net loss of ₹6 Cr on sales of just ₹1 Cr.
• Piotroski F-Score of 3/9 signals weak financial health and deteriorating fundamentals.
• No dividend means shareholders receive no income while waiting for a turnaround or asset realization.
• Promoter holding is undisclosed, leaving outside investors without clarity on owner alignment.

AI Analysis

Morgan Ventures is a classic Graham-type bargain, but I have to ask whether the business deserves to survive. At ₹48.06, the market values the entire company at ₹50 crore, yet the balance sheet shows book value of ₹84 per share. That is a 43% discount. Buying a rupee for 57 paise is appealing, but only if that rupee is sound. This is an NBFC, so the true worth lives in the quality of its loan and investment assets, not in reported sales. The latest figures disturb me. Sales have collapsed by 91%, the most recent quarter earned just ₹1 crore of revenue and lost ₹6 crore. With a Piotroski score of just 3, the financial condition is weak. A low P/B can be a value trap when earnings are falling. ROCE of 18.33% suggests the capital historically worked well, but current profit growth of -159% means that return is not being repeated. There is no dividend, so the shareholder cannot even be paid to wait. I would need to verify the book value: are the assets marked at fair value, are there hidden NPA problems, and can the losses stop? If the ₹84 book value is hard and the losses are temporary, this is an asset play; if not, the discount will keep widening. I would not rush. In Benjamin Graham's language, price is what you pay, and value is what you get—here the price is low, but the value is unproven. Only concrete improvement in quarterly profits will convince me to act.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer